Oceania

Australia Significant Investor Visa (SIV) - Subclass 188/888

Path to Australian permanent residence through AUSD 5.0M+ complying investment. High quality of life with access to world-class healthcare and education.

Significant Investor Visa (SIV) flag

Program overview

Status
Discontinued
Minimum Investment
USD 5.0M
Established
2012
Processing Time
1-3 months
Schengen Access
No
Schedule consultation

Investment options

Investment Funds
USD 5.0M

Citizenship requirements

Eligibility
After 4 years
Language
Not required
Test
Required

Key benefits

Travel to Australian passport very strong

Family inclusion

Spouse
Dependent children up to age 18

Tax situation

Income Tax
0-45%
Foreign Income
Taxed
Capital Gains
22.5%
Dividends
Imputation
Wealth Tax
None
Inheritance Tax
None

Program details

Program Ceased: The Business Innovation and Investment Program (BIIP), which included the Significant Investor Visa (SIV), was abolished in September 2024. The government cited concerns about economic impact, fraud, and national security.

When operational, the SIV required AUD 5M in compliant investments: AUD 500K in venture capital/private equity, AUD 1.5M in emerging companies funds, and AUD 3M in balancing investments. The program offered a pathway to permanent residency after 4 years with minimal physical presence requirements (40 days per year).

Refunds have been provided for withdrawn applications. Opposition Leader Peter Dutton has announced plans to revive the SIV if elected.

Alternative: The National Innovation Visa (subclass 858) remains available as a separate talent-based pathway for those with exceptional achievements in their field.

Interested in Australia's Significant Investor Visa (SIV) - Subclass 188/888?

Our advisors can guide you through the application process and help you evaluate if this program fits your goals.

Schedule consultation

Expert guidance

Find your path to permanent residency

Our advisors help you compare programs, understand citizenship timelines, and structure your investment for maximum benefit.

Schedule consultation